Literature DB >> 2439334

Botulinum toxin A blocks glutamate exocytosis from guinea-pig cerebral cortical synaptosomes.

J Sanchez-Prieto, T S Sihra, D Evans, A Ashton, J O Dolly, D G Nicholls.   

Abstract

The exocytotic release of L-glutamate from guinea-pig cerebral cortical synaptosomes can be extensively inhibited by preincubation with botulinum neurotoxin type A at 37 degrees C for 1-2 h. The toxin has no effect on synaptosomal respiratory control, respiratory capacity, ATP synthesis, plasma-membrane 86Rb+ permeability or plasma-membrane potential, does not inhibit the entry of 45Ca2+ into the synaptosome upon depolarization and does not alter the ability of intrasynaptosomal mitochondria to sequester Ca2+. The blockade of Ca2+-dependent glutamate release may be totally reversed by the Ca2+/2 H+-exchange ionophore ionomycin, but not by increasing extracellular Ca2+ concentration. It is suggested (a) that exocytosis is triggered by the penetration of Ca2+ into an intracellular hydrophobic milieu; (b) that this stage is blocked by the toxin and (c) that ionomycin is able to bypass this block and deliver Ca2+ to the exocytotic apparatus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2439334     DOI: 10.1111/j.1432-1033.1987.tb11494.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Release of dopamine from human neocortex nerve terminals evoked by different stimuli involving extra- and intraterminal calcium.

Authors:  G Bonanno; R Sala; L Cancedda; P Cavazzani; M Cossu; M Raiteri
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

Review 2.  Bioenergetics and transmitter release in the isolated nerve terminal.

Authors:  David G Nicholls
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

Review 3.  Clostridium botulinum toxins: a general review of involvement in disease, structure, mode of action and preparation for clinical use.

Authors:  P Hambleton
Journal:  J Neurol       Date:  1992-01       Impact factor: 4.849

4.  Neurotransmitter release is blocked intracellularly by botulinum neurotoxin, and this requires uptake of both toxin polypeptides by a process mediated by the larger chain.

Authors:  B Poulain; L Tauc; E A Maisey; J D Wadsworth; P M Mohan; J O Dolly
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

Review 5.  Action of botulinum neurotoxins in the central nervous system: antiepileptic effects.

Authors:  Y Bozzi; L Costantin; F Antonucci; M Caleo
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

6.  Botulinum Injection Into the Proximal Intestinal Wall of Diet-Induced Obese Mice Leads to Weight Loss and Improves Glucose and Fat Tolerance.

Authors:  Sinju Sundaresan; Joseph Antoun; Babak Banan; Jamie Adcock; Connor Johnson; Brendan Claire; Kala Dixon; Joyce Flynn; Cyndya A Shibao; Naji Abumrad
Journal:  Diabetes       Date:  2022-07-01       Impact factor: 9.337

7.  Response of thalamocortical neurons to hypoxia: a whole-cell patch-clamp study.

Authors:  G Erdemli; V Crunelli
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

Review 8.  Bacterial toxins and the nervous system: neurotoxins and multipotential toxins interacting with neuronal cells.

Authors:  Michel R Popoff; Bernard Poulain
Journal:  Toxins (Basel)       Date:  2010-04-15       Impact factor: 4.546

Review 9.  Botulinum neurotoxin for pain management: insights from animal models.

Authors:  Flaminia Pavone; Siro Luvisetto
Journal:  Toxins (Basel)       Date:  2010-12-21       Impact factor: 4.546

10.  Preferential entry of botulinum neurotoxin A Hc domain through intestinal crypt cells and targeting to cholinergic neurons of the mouse intestine.

Authors:  Aurélie Couesnon; Jordi Molgó; Chloé Connan; Michel R Popoff
Journal:  PLoS Pathog       Date:  2012-03-15       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.